WallStreetZenWallStreetZen

NASDAQ: SPRB
Spruce Biosciences Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for SPRB

Based on 1 analyst offering 12 month price targets for Spruce Biosciences Inc

Min Forecast
$0.50-94.9%
Avg Forecast
$0.50-94.9%
Max Forecast
$0.50-94.9%

Should I buy or sell SPRB stock?

Based on 1 analyst offering ratings for Spruce Biosciences Inc.

Hold
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
1 analysts 100%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their SPRB stock forecasts and price targets.

SPRB stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-04-16

1 of 1

Forecast return on equity

Is SPRB forecast to generate an efficient return?

Company
-7.99%
Industry
131.35%
Market
-50.97%
SPRB's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is SPRB forecast to generate an efficient return on assets?

Company
-4.83%
Industry
47.84%
SPRB is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

SPRB earnings per share forecast

What is SPRB's earnings per share in the next 3 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$2.83
Avg 2 year Forecast
-$11.31
Avg 3 year Forecast
-$10.52

SPRB revenue forecast

What is SPRB's revenue in the next 1 years based on estimates from 1 analyst?

Avg 1 year Forecast
$2.0M+53.96%
SPRB's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

SPRB revenue growth forecast

How is SPRB forecast to perform vs Biotechnology companies and vs the US market?

Company
61.78%
Industry
85.89%
Market
10.84%
SPRB's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
SPRB's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

SPRB vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
SPRB$9.80$0.50-94.90%Hold
CMND$1.03N/AN/A
BCTX$8.09$40.00+394.44%Buy
SXTP$1.37$3.00+118.98%Buy
PALI$0.59$16.00+2,602.70%Strong Buy
View Top Biotech Stocks

Spruce Biosciences Stock Forecast FAQ

Is Spruce Biosciences Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: SPRB) stock is to Hold SPRB stock.

Out of 1 analyst, 0 (0%) are recommending SPRB as a Strong Buy, 0 (0%) are recommending SPRB as a Buy, 1 (100%) are recommending SPRB as a Hold, 0 (0%) are recommending SPRB as a Sell, and 0 (0%) are recommending SPRB as a Strong Sell.

If you're new to stock investing, here's how to buy Spruce Biosciences stock.

What is SPRB's earnings growth forecast for 2025-2027?

(NASDAQ: SPRB) Spruce Biosciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 5.13%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.27%.

Spruce Biosciences's earnings in 2025 is -$48,338,000.On average, 1 Wall Street analyst forecast SPRB's earnings for 2025 to be -$1,593,409, with the lowest SPRB earnings forecast at -$1,593,409, and the highest SPRB earnings forecast at -$1,593,409. On average, 1 Wall Street analyst forecast SPRB's earnings for 2026 to be -$6,368,005, with the lowest SPRB earnings forecast at -$6,368,005, and the highest SPRB earnings forecast at -$6,368,005.

In 2027, SPRB is forecast to generate -$5,923,202 in earnings, with the lowest earnings forecast at -$5,923,202 and the highest earnings forecast at -$5,923,202.

What is SPRB's revenue growth forecast for 2025-2025?

(NASDAQ: SPRB) Spruce Biosciences's forecast annual revenue growth rate of 61.78% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 85.89%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.84%.

Spruce Biosciences's revenue in 2025 is $1,299,000.

In 2025, SPRB is forecast to generate $1,126,084 in revenue, with the lowest revenue forecast at $1,126,084 and the highest revenue forecast at $1,126,084.

What is SPRB's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: SPRB) forecast ROA is -4.83%, which is lower than the forecast US Biotechnology industry average of 47.84%.

What is SPRB's Price Target?

According to 1 Wall Street analyst that have issued a 1 year SPRB price target, the average SPRB price target is $0.50, with the highest SPRB stock price forecast at $0.50 and the lowest SPRB stock price forecast at $0.50.

The Wall Street analyst predicted that Spruce Biosciences's share price could fall to $0.50 by Apr 16, 2026. The average Spruce Biosciences stock price prediction forecasts a potential downside of 94.9% from the current SPRB share price of $9.80.

What is SPRB's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: SPRB) Spruce Biosciences's current Earnings Per Share (EPS) is -$86.30. On average, analysts forecast that SPRB's EPS will be -$2.83 for 2025, with the lowest EPS forecast at -$2.83, and the highest EPS forecast at -$2.83. On average, analysts forecast that SPRB's EPS will be -$11.31 for 2026, with the lowest EPS forecast at -$11.31, and the highest EPS forecast at -$11.31. In 2027, SPRB's EPS is forecast to hit -$10.52 (min: -$10.52, max: -$10.52).

What is SPRB's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: SPRB) forecast ROE is -7.99%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.